Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates.
Engberg J, Aarestrup FM, Taylor DE, Gerner-Smidt P, Nachamkin I. · 2001
Read Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates. by Engberg J, Aarestrup FM, Taylor DE, Gerner-Smidt P, Nachamkin I. (2001) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc2631682.txt.
Description
Engberg, Aarestrup, Taylor, Gerner-Smidt, and Nachamkin reviewed in 2001 how Campylobacter bacteria are becoming resistant to the two antibiotic families used against them. Human infections with Campylobacter jejuni and C. coli had risen markedly over the previous decade, and resistant strains were rising with them. The authors tracked resistance trends in human isolates and related them to antibiotic use in food animals.
Quinolone resistance had grown enough that the review warns fluoroquinolones may now be of limited use for empiric treatment, treating before test results, in many regions. Macrolide resistance remained less common, so erythromycin and related macrolides should stay the drugs of choice in most areas. The authors call for systematic surveillance and control measures to be maintained. They link veterinary drug use to the human treatment problem.
Catalog record
| CREATOR | Engberg J, Aarestrup FM, Taylor DE, Gerner-Smidt P, Nachamkin I. |
|---|---|
| YEAR | 2001 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 16 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |